Back to search

Article

The amino acid transporter SLC7A5 drives progression of PI3K-mutant intestinal cancer models and enhances response to MAPK-targeted therapy

2024-09-26

Abstract excerpt

<title>Abstract</title> <p>Colorectal cancer (CRC) is a complex disease with key oncogenic pathways, including Wnt, MAPK, and PI3K, co-operating to drive tumour initiation and progression. Loss-of-function mutations in the Wnt-pathway inhibitor <italic>APC</italic> are the most prominent genetic alterations and are commonly seen as the tumour-initiating event. Here, we have used genetically engineered mouse model...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cd35c0cf-9646-553b-a888-614141fe3acb
DOI
10.21203/rs.3.rs-5002395/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The amino acid transporter SLC7A5 drives progression of PI3K-mutant intestinal cancer models and enhances response to MAPK-targeted therapyDOI 10.21203/rs.3.rs-5002395/v1
Select a neighboring publication to make it the new centre.